Find comprehensive information on Tubo-Ovarian Abscess including clinical documentation, diagnosis codes (ICD-10 N70.9, SNOMED CT), treatment options, and healthcare guidelines. Learn about pelvic inflammatory disease PID, adnexal mass, and ruptured ovarian cyst related to TOA. This resource offers insights for healthcare professionals, medical coders, and patients seeking information on Tubo-Ovarian Abscess symptoms, diagnosis, and management.
Also known as
Diseases of female genital organs
Inflammatory diseases of the female pelvic organs.
Infections with a predominantly sexual mode of transmission
Sexually transmitted infections can cause pelvic inflammatory disease and abscesses.
Noninfective disorders of female genital tract
Other complications of female genital organs can sometimes mimic or lead to abscesses.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the tubo-ovarian abscess ruptured?
When to use each related code
| Description |
|---|
| Tubo-ovarian abscess |
| Pelvic inflammatory disease |
| Ovarian abscess |
Missing or incorrect laterality (right, left, bilateral) for the Tubo-Ovarian Abscess can impact reimbursement and data accuracy. ICD-10-CM coding guidelines require laterality specification.
Failure to document and code the causative organism if known (e.g., N70.9, Tubo-ovarian abscess, unspecified) impacts severity tracking and may affect quality reporting. CDI queries can clarify.
Distinguishing between ruptured (N70.1) and unruptured (N70.0) Tubo-Ovarian Abscess is crucial for accurate coding, reflecting different levels of severity and resource utilization.
Q: What are the most specific imaging findings suggestive of a tubo-ovarian abscess (TOA) requiring drainage, and how do they differentiate it from other pelvic inflammatory disease complications?
A: While pelvic inflammatory disease (PID) often presents with complex imaging findings, certain features are highly suggestive of a TOA requiring drainage. Specifically, a multilocular complex fluid collection in the adnexa with thick, irregular walls, internal debris, and enhancing rim on CT or MRI is highly concerning for a TOA. Presence of gas within the collection further strengthens the diagnosis. Differentiating a TOA from other PID complications like hydrosalpinx or pyosalpinx relies on identifying the size and complexity of the fluid collection. TOAs tend to be larger and more heterogeneous than hydrosalpinges (simple fluid-filled fallopian tubes) or pyosalpinges (pus-filled tubes without loculations or debris). Furthermore, the surrounding inflammatory changes in TOA are often more pronounced. Consider implementing a standardized imaging review protocol for suspected TOA to ensure accurate and timely diagnosis. Explore how advancements in Doppler ultrasound can aid in evaluating vascularity and confirming the presence of abscesses.
Q: Beyond broad-spectrum antibiotics, what are the current best-practice guidelines for managing a ruptured tubo-ovarian abscess in a hemodynamically unstable patient, considering both immediate and long-term management strategies?
A: Management of a ruptured TOA in a hemodynamically unstable patient requires a multidisciplinary approach. Immediate resuscitation with intravenous fluids and vasopressors is crucial to stabilize the patient. Source control through prompt surgical intervention, typically laparoscopy or laparotomy, is necessary to drain the abscess and remove the ruptured structure. While broad-spectrum antibiotics covering polymicrobial pelvic flora are essential, source control is paramount in these cases. Long-term management involves completing the antibiotic course, typically for 14 days, and addressing underlying risk factors for PID, such as sexually transmitted infections. Post-operative follow-up is crucial to monitor for complications like sepsis, pelvic adhesions, and infertility. Learn more about the role of minimally invasive surgery in managing complex TOA and explore the latest research on long-term outcomes following ruptured TOA.
Patient presents with complaints consistent with a tubo-ovarian abscess (TOA). Symptoms include pelvic pain, lower abdominal pain, fever, chills, vaginal discharge, and nausea. Physical examination reveals abdominal tenderness, cervical motion tenderness, and adnexal mass. Differential diagnoses considered include pelvic inflammatory disease (PID), appendicitis, ectopic pregnancy, ovarian cyst, and endometriosis. Laboratory findings indicate leukocytosis and elevated inflammatory markers (CRP, ESR). Pelvic ultrasound demonstrates a complex adnexal mass with features suggestive of a tubo-ovarian abscess, including thick walls, internal debris, and possibly free fluid in the pelvis. The patient's presentation, physical exam findings, and imaging results support the diagnosis of tubo-ovarian abscess. Treatment plan includes intravenous antibiotics targeting polymicrobial infection, pain management, and possible drainage procedures such as percutaneous or surgical drainage if indicated by clinical response or abscess size. Patient education provided on risks, benefits, and alternatives to treatment options. Close monitoring for treatment response and potential complications such as sepsis or rupture is warranted. Follow-up appointment scheduled for reassessment and further management. ICD-10 code N70.1 (Tubo-ovarian abscess and other inflammatory diseases of ovary, fallopian tube, and broad ligament) assigned.